drug protocol number

SCT22R/016/12

drug sponsor

King Abdullah International Medical Research Center (KAIMRC)

drug study

BLINATUMOMAB

drug trial site

King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Medical City NG (Jeddah)

drug status

Ongoing

drug phase